Immunovant, Inc. (IMVT) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|
| Total Current Assets | 948.82M | 1.04B | 573.55M | 651.76M | 767.66M | 412.54M | 507.37M | 589.05M | 665.77M | 710.78M | 291.18M | 350.01M | 404.33M | 454.42M | 426.09M | 456.3M | 512.93M | 540.48M | 563.79M | 384.83M |
| Cash & Short-Term Investments | 902.11M | 994.52M | 521.87M | 598.91M | 713.97M | 374.69M | 472.94M | 560M | 635.37M | 690.94M | 269.93M | 329.96M | 376.53M | 432.61M | 405.77M | 427.2M | 493.82M | 527M | 558.95M | 379M |
| Cash Only | 902.11M | 994.52M | 521.87M | 598.91M | 713.97M | 374.69M | 472.94M | 560M | 635.37M | 690.94M | 269.93M | 329.96M | 376.53M | 432.61M | 405.77M | 427.2M | 493.82M | 527M | 558.95M | 379M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.95M | 1.64M | 1.97M | 1.94M | 2.51M | 2.22M | 1.88M | 2.42M | 5.5M | 1.03M | 1.42M | 823K | 885K | 704K | 3.78M | 13.18M | 12.86M | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 42.76M | 46.77M | 49.71M | 50.91M | 51.18M | 35.63M | 32.55M | 26.63M | 24.9M | 18.81M | 19.83M | 19.23M | 0 | 21.11M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 8.2M | 9.45M | 9.41M | 9.68M | 8.56M | 8.39M | 8.34M | 631K | 942K | 670K | 893K | 1.21M | 1.5M | 1.82M | 2.06M | 2.35M | 2.63M | 2.7M | 2.94M | 3.2M |
| Property, Plant & Equipment | 515K | 531K | 632K | 737K | 942K | 774K | 716K | 631K | 595K | 670K | 893K | 1.21M | 1.5M | 1.82M | 2.06M | 2.35M | 2.63M | 2.7M | 2.94M | 3.2M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 7.68M | 8.92M | 8.78M | 8.94M | 7.62M | 7.62M | 7.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 957.01M | 1.05B | 582.96M | 661.44M | 776.22M | 420.93M | 515.71M | 589.68M | 666.71M | 711.45M | 292.07M | 351.22M | 405.84M | 456.24M | 428.15M | 458.66M | 515.56M | 543.18M | 566.73M | 388.03M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 23.29% | 150.01% | 13.04% | 12.17% | 16.43% | -40.83% | 76.57% | 67.89% | 64.28% | 55.94% | -31.78% | -23.42% | -21.28% | -16.01% | -24.45% | 18.2% | 24.99% | 25.44% | 24.86% | 33.67% |
| Total Current Liabilities | 104.42M | 66.26M | 63.25M | 52.9M | 68.78M | 68.31M | 66.65M | 45.02M | 48.61M | 32.1M | 40.26M | 51.36M | 43.3M | 41.26M | 31.78M | 21.24M | 44.52M | 36.35M | 28.38M | 20.52M |
| Accounts Payable | 7.54M | 8.62M | 6.92M | 7.84M | 17.66M | 19.82M | 20.73M | 11.04M | 7.16M | 3.91M | 7.51M | 26.46M | 1.35M | 14M | 7.46M | 1.07M | 18.63M | 3.83M | 4.24M | 3.11M |
| Days Payables Outstanding | - | 7.07K | 6.47K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 138K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 16.77M | 57.64M | 56.34M | 39.08M | 15.62M | 11.25M | 7.06M | 3.4M | 26.57M | 7.47M | 4.85M | 2.44M | 350K | 5.34M | 3.61M | 2.04M | 171K | 2.51M | 1.79M | 1.35M |
| Current Ratio | 9.09x | 15.74x | 9.07x | 12.32x | 11.16x | 6.04x | 7.61x | 13.08x | 13.70x | 22.14x | 7.23x | 6.82x | 9.34x | 11.01x | 13.41x | 21.48x | 11.52x | 14.87x | 19.86x | 18.75x |
| Quick Ratio | 9.09x | 15.74x | 9.07x | 12.32x | 11.16x | 6.04x | 7.61x | 13.08x | 13.70x | 22.14x | 7.23x | 6.82x | 9.34x | 11.01x | 13.41x | 21.48x | 11.52x | 14.87x | 19.86x | 18.75x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 347K | 0 | 0 | 0 | 47K | 306K | 614K | 919K | 1.22M | 1.68M | 1.95M | 1.97M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47K | 306K | 614K | 919K | 1.22M | 1.68M | 1.95M | 1.97M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 347K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 104.42M | 66.26M | 63.25M | 52.9M | 68.78M | 68.31M | 66.65M | 45.02M | 48.95M | 32.1M | 40.26M | 51.36M | 43.34M | 41.56M | 32.4M | 22.16M | 45.74M | 38.03M | 30.34M | 22.5M |
| Total Debt | 72K | 0 | 0 | 0 | 98K | 23K | 47K | 69K | 138K | 306K | 614K | 919K | 1.22M | 1.51M | 1.8M | 2.08M | 2.36M | 2.76M | 3.03M | 3.06M |
| Net Debt | -902.04M | -994.52M | -521.87M | -598.91M | -713.87M | -374.66M | -472.89M | -559.94M | -635.23M | -690.63M | -269.31M | -329.04M | -375.31M | -431.1M | -403.97M | -425.12M | -491.45M | -524.24M | -555.92M | -375.95M |
| Debt / Equity | 0.00x | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 852.59M | 986.13M | 519.71M | 608.54M | 707.45M | 352.62M | 449.05M | 544.66M | 617.76M | 679.34M | 251.81M | 299.87M | 362.49M | 414.68M | 395.75M | 436.49M | 469.82M | 505.15M | 536.4M | 365.53M |
| Equity Growth % | 20.52% | 179.66% | 15.73% | 11.73% | 14.52% | -48.09% | 78.33% | 81.64% | 70.42% | 63.82% | -36.37% | -31.3% | -22.84% | -17.91% | -26.22% | 19.41% | 20.01% | 21.97% | 22.35% | 36.51% |
| Book Value per Share | 4.19 | 5.43 | 2.99 | 3.56 | 4.67 | 2.40 | 3.07 | 3.73 | 4.25 | 4.70 | 1.92 | 2.30 | 2.80 | 3.23 | 3.39 | 3.74 | 4.04 | 4.39 | 4.92 | 3.73 |
| Total Shareholders' Equity | 852.59M | 986.13M | 519.71M | 608.54M | 707.45M | 352.62M | 449.05M | 544.66M | 617.76M | 679.34M | 251.81M | 299.87M | 362.49M | 414.68M | 395.75M | 436.49M | 469.82M | 505.15M | 536.4M | 365.53M |
| Common Stock | 20K | 20K | 17K | 16K | 16K | 14K | 14K | 14K | 14K | 14K | 13K | 13K | 13K | 13K | 12K | 12K | 12K | 12K | 12K | 10K |
| Retained Earnings | -1.75B | -1.6B | -1.49B | -1.36B | -1.24B | -1.13B | -1.02B | -912.83M | -825.68M | -750.36M | -698.95M | -640.28M | -566.35M | -506.92M | -443.69M | -395.76M | -355.39M | -308.22M | -266.83M | -229.13M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 730K | 1.2M | 1.45M | 1.74M | 1.46M | 2.48M | 1.91M | 1.82M | 1.91M | -600K | 513K | 582K | 852K | 1.38M | -1.24M | -263K | 404K | 419K | 442K | 273K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |